{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:53:57Z","timestamp":1789505637814,"version":"build-2803163510"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5,15]]},"DOI":"10.1097\/tp.0b013e3181a2e295","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T21:18:53Z","timestamp":1242940733000},"page":"S95-S99","source":"Crossref","is-referenced-by-count":18,"title":["Using Biomarkers of Tolerance and Rejection to Identify High- and Low-Risk Patients Following Kidney Transplantation"],"prefix":"10.1097","volume":"87","author":[{"given":"Joanna","family":"Ashton-Chess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Giral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Soulillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Brouard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20-20210211","first-page":"S89","article-title":"Controlling the incidence of infection and malignancy by modifying immunosuppression.","volume":"72","author":"Soulillou","year":"2001","journal-title":"Transplantation"},{"key":"R2-20-20210211","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(95)92780-8","article-title":"Risk of neoplasia in renal transplant patients.","volume":"346","author":"London","year":"1995","journal-title":"Lancet"},{"key":"R3-20-20210211","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/01.TP.0000128636.70499.6E","article-title":"Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology.","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"R4-20-20210211","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/172603a0","article-title":"Activity acquired tolerance of foreign cells.","volume":"172","author":"Billingham","year":"1953","journal-title":"Nature"},{"key":"R5-20-20210211","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1432-2277.2006.00339.x","article-title":"Is clinical tolerance realistic in the next decade?","volume":"19","author":"Ashton-Chess","year":"2006","journal-title":"Transpl Int"},{"key":"R6-20-20210211","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1111\/j.1600-6143.2006.01434.x","article-title":"Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: In vivo and in vitro analyses.","volume":"6","author":"Fudaba","year":"2006","journal-title":"Am J Transplant"},{"key":"R7-20-20210211","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1056\/NEJMoa071074","article-title":"HLA-mismatched renal transplantation without maintenance immunosuppression.","volume":"358","author":"Kawai","year":"2008","journal-title":"N Engl J Med"},{"key":"R8-20-20210211","first-page":"278","article-title":"Cessation of immunosuppression after renal transplantation.","volume":"79","author":"Uehling","year":"1976","journal-title":"Surgery"},{"key":"R9-20-20210211","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00007890-199504270-00013","article-title":"Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient.","volume":"59","author":"Burlingham","year":"1995","journal-title":"Transplantation"},{"key":"R10-20-20210211","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1084\/jem.20031012","article-title":"Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance.","volume":"199","author":"Cai","year":"2004","journal-title":"J Exp Med"},{"key":"R11-20-20210211","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1600-6143.2006.01280.x","article-title":"Clinical operational tolerance after kidney transplantation.","volume":"6","author":"Roussey-Kesler","year":"2006","journal-title":"Am J Transplant"},{"key":"R12-20-20210211","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1097\/01.tp.0000290683.54937.1b","article-title":"Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation.","volume":"84","author":"Ashton-Chess","year":"2007","journal-title":"Transplantation"},{"key":"R13-20-20210211","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1600-6143.2006.01396.x","article-title":"An appraisal of tolerance in liver transplantation.","volume":"6","author":"Lerut","year":"2006","journal-title":"Am J Transplant"},{"key":"R14-20-20210211","first-page":"2845","article-title":"Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients.","volume":"118","author":"Martinez-Llordella","year":"2008","journal-title":"J Clin Invest"},{"key":"R15-20-20210211","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1681\/ASN.2004030209","article-title":"Impact of graft mass on the clinical outcome of kidney transplants.","volume":"16","author":"Giral","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R16-20-20210211","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1034\/j.1600-6143.2003.00135.x","article-title":"Humoral theory of transplantation.","volume":"3","author":"Terasaki","year":"2003","journal-title":"Am J Transplant"},{"key":"R17-20-20210211","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2004.00360.x","article-title":"Predicting kidney graft failure by HLA antibodies: A prospective trial.","volume":"4","author":"Terasaki","year":"2004","journal-title":"Am J Transplant"},{"key":"R18-20-20210211","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/01.tp.0000174338.97313.5a","article-title":"Predictive value of HLA antibodies and serum creatinine in chronic rejection: Results of a 2-year prospective trial.","volume":"80","author":"Terasaki","year":"2005","journal-title":"Transplantation"},{"key":"R19-20-20210211","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1681\/ASN.V123574","article-title":"Chronic humoral rejection: Identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries.","volume":"12","author":"Mauiyyedi","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R20-20-20210211","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1097\/01.ASN.0000025780.03790.0F","article-title":"Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection.","volume":"13","author":"Regele","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R21-20-20210211","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff'05 Meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (\u201cCAN\u201d).","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant"},{"key":"R22-20-20210211","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/sj.ki.5002003","article-title":"The classification and treatment of antibody-mediated renal allograft injury: Where do we stand?","volume":"71","author":"Nickeleit","year":"2007","journal-title":"Kidney Int"},{"key":"R23-20-20210211","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework.","volume":"69","author":"Atkinson","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"R24-20-20210211","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2215\/CJN.00390705","article-title":"Protocol transplant biopsies: An underutilized tool in kidney transplantation.","volume":"1","author":"Rush","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R25-20-20210211","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.trre.2006.09.001","article-title":"Tolerance assays: The physician's guide to safe weaning of immunosuppression?","volume":"20","author":"Lau","year":"2006","journal-title":"Transplantation Reviews"},{"key":"R26-20-20210211","first-page":"337","article-title":"A practical approach to immune monitoring in kidney transplantation.","volume":"59","author":"Rodrigo","year":"2007","journal-title":"Minerva Urol Nefrol"},{"key":"R27-20-20210211","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1600-6143.2004.00700.x","article-title":"Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation.","volume":"5","author":"Brouard","year":"2005","journal-title":"Am J Transplant"},{"key":"R28-20-20210211","first-page":"403","article-title":"Discrimination of kidney transplant recipients presenting operational tolerance or chronic rejection based on recognition of T cell receptor cdr3 length distribution patterns Abstract No. 998.","volume":"6","author":"Miqueu","year":"2006","journal-title":"Am J Transplant"},{"key":"R30-20-20210211","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/j.1432-2277.2007.00537.x","article-title":"Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome.","volume":"20","author":"Braudeau","year":"2007","journal-title":"Transpl Int"},{"key":"R31-20-20210211","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1600-6143.2006.01621.x","article-title":"Multiparameter immune profiling of operational tolerance in liver transplantation.","volume":"7","author":"Martinez-Llordella","year":"2007","journal-title":"Am J Transplant"},{"key":"R32-20-20210211","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.4049\/jimmunol.178.6.3983","article-title":"Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance.","volume":"178","author":"Xu","year":"2007","journal-title":"J Immunol"},{"key":"R33-20-20210211","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.tp.0000203166.44968.86","article-title":"Contrasting CD25hiCD4+T cells\/FOXP3 patterns in chronic rejection and operational drug-free tolerance.","volume":"81","author":"Louis","year":"2006","journal-title":"Transplantation"},{"key":"R37-20-20210211","doi-asserted-by":"crossref","first-page":"15448","DOI":"10.1073\/pnas.0705834104","article-title":"Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance.","volume":"104","author":"Brouard","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"R38-20-20210211","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/jcb.21574","article-title":"Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis.","volume":"103","author":"Braud","year":"2008","journal-title":"J Cell Biochem"},{"key":"R40-20-20210211","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1681\/ASN.2007101056","article-title":"Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection.","volume":"19","author":"Ashton-Chess","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R41-20-20210211","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/TP.0b013e31817b8dc5","article-title":"The immunoproteasome beta subunit ten is increased in chronic antibody-mediated rejection; proteasome inhibition as a novel therapeutic strategy. Submitted. 42. Braudeau C, Ashton-Chess J, Giral M, et al. Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients.","volume":"86","author":"J","year":"2008","journal-title":"Transplantation"},{"key":"R42-20-20210211","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/TP.0b013e31817b8dc5","article-title":"Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients.","volume":"86","author":"Braudeau","year":"2008","journal-title":"Transplantation"},{"key":"R43-20-20210211","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/01.tp.0000203324.49969.30","article-title":"Regulatory, effector and cytotoxic profiles in long-term kidney transplant patients. J. Am. Soc. Nephrol. In press. 44. Sengul S, Keven K, Gormez U, et al. Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation.","volume":"81","author":"Ashton-Chess","year":"2006","journal-title":"Transplantation"},{"key":"R44-20-20210211","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/01.tp.0000203324.49969.30","article-title":"Identification of patients at risk of acute rejection by pretransplantation and posttransplantation monitoring of soluble CD30 levels in kidney transplantation.","volume":"81","author":"Sengul","year":"2006","journal-title":"Transplantation"},{"key":"R45-20-20210211","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM200103293441301","article-title":"Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine.","volume":"344","author":"Li","year":"2001","journal-title":"N Engl J Med"},{"key":"R46-20-20210211","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/sj.ki.5000343","article-title":"Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short- and long-term graft function.","volume":"69","author":"Matz","year":"2006","journal-title":"Kidney Int"},{"key":"R47-20-20210211","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa051907","article-title":"Messenger RNA for FOXP3 in the urine of renal-allograft recipients.","volume":"353","author":"Muthukumar","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00007890-200905151-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T02:11:25Z","timestamp":1633486285000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-200905151-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,15]]},"references-count":42,"journal-issue":{"issue":"9S","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0b013e3181a2e295","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5,15]]}}}